InvestorsHub Logo
Followers 92
Posts 5943
Boards Moderated 0
Alias Born 09/30/2005

Re: elysse1kittycat post# 86018

Saturday, 07/04/2015 9:04:56 PM

Saturday, July 04, 2015 9:04:56 PM

Post# of 92948
Also, the same Board that allowed rabin to 'negotiate' over 52 cases of toxic financing that cost ACT millions and millions and set it back years; the same Board that allowed rabin to manuever into the ceo spot and then hired him and the same Board who created all the costly legal problems with the SEC, and then the same Board that used shareholders money to pay rabin's $325,000. fine so the company could mover on, and then the same Board who supposedly comprised of the most respected and intelligent individuals in biotech 'fraternity', oh, world, hired double talk wotton, along with the wonderful Board struck out on a 62 mil. secondary and who knows what on the recent share sale, who now have Ocata fighting for it's life anyway it deceptively can, while the stock is now truly just a tiny fraction over 5 cents a share.
Great Board and great management. What's next?
Well, for one, keeping the register ringing for the mm and the hedgies, etc., while continuing to meet payroll and pay rent while all these new prestigious in name hedge players have been given more food to gorge themselves on by their comrades on the Board and the management

When it smells, it's usually foul.
Takes much more to convince me this remains a viable investment, like some word on definite and sufficient dollars and some word that phase 2 has started and far less 'rabbits out of the hat' while these guys jaunt to sweeden and eat filet mignon. At our expense.
Sad really.
After almost 8 years of an incredible stock market soon to come to some kind of ending, and a market overflowing with dollars for developing biotechs, we come up empty and selling for 5 cents.
Great investment. Great future promise.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.